Showing 1 - 4 results of 4 for search 'Chi-Chang Weng', query time: 0.03s Refine Results
  1. 1
    Bone Morphogenetic Protein-, Antimicrobial Agent-, and Analgesic-Incorporated Nanofibrous Scaffolds for the Therapy of Alveolar Clefts

    Bone Morphogenetic Protein-, Antimicrobial Agent-, and Analgesic-Incorporated Nanofibrous Scaffolds for the Therapy of Alveolar Clefts by Pang-Yun Chou, Demei Lee, Chi-Chang Weng, Ren-Chin Wu, Chien-Tun Liao, Shih-Jung Liu

    Published 2022-02-01
    Get full text
    Article
  2. 2
    Characterization of Sigma-2 Receptor—Specific Binding Sites Using [<sup>3</sup>H]DTG and [<sup>125</sup>I]RHM-4

    Characterization of Sigma-2 Receptor—Specific Binding Sites Using [<sup>3</sup>H]DTG and [<sup>125</sup>I]RHM-4 by Chi-Chang Weng, Aladdin Riad, Brian P. Lieberman, Kuiying Xu, Xin Peng, John L. Mikitsh, Robert H. Mach

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Glycolytic Plasticity of Metastatic Lung Cancer Captured by Noninvasive <sup>18</sup>F-FDG PET/CT and Serum <sup>1</sup>H-NMR Analysis: An Orthotopic Murine Model Study

    Glycolytic Plasticity of Metastatic Lung Cancer Captured by Noninvasive <sup>18</sup>F-FDG PET/CT and Serum <sup>1</sup>H-NMR Analysis: An Orthotopic Murine Model Study by Yi-Hsiu Chung, Tsai-Hsien Hung, Ching-Fang Yu, Cheng-Kun Tsai, Chi-Chang Weng, Fujie Jhang, Fang-Hsin Chen, Gigin Lin

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Characterization of <sup>18</sup>F-PM-PBB3 (<sup>18</sup>F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy

    Characterization of <sup>18</sup>F-PM-PBB3 (<sup>18</sup>F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy by Chi-Chang Weng, Ing-Tsung Hsiao, Qing-Fang Yang, Cheng-Hsiang Yao, Chin-Yin Tai, Meng-Fang Wu, Tzu-Chen Yen, Ming-Kuei Jang, Kun-Ju Lin

    Published 2020-04-01
    Get full text
    Article

Search Tools: